Education
About Us
Working with TipRanks
Follow Us
Bio-Rad Laboratories (BIO)
NYSE:BIO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.57B | $ 2.67B | $ 2.80B | $ 2.92B | $ 2.55B |
| Gross Profit | $ 1.38B | $ 1.43B | $ 1.57B | $ 1.64B | $ 1.44B |
| Operating Income | $ 269.00M | $ 337.80M | $ 482.62M | $ 489.43M | $ 410.96M |
| EBITDA | $ -2.14B | $ -608.26M | $ -4.49B | $ 5.63B | $ 5.10B |
| Net Income | $ -1.84B | $ -637.32M | $ -3.63B | $ 4.25B | $ 3.81B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.18B | $ 1.61B | $ 1.80B | $ 875.48M | $ 996.68M |
| Total Assets | $ 9.36B | $ 12.30B | $ 13.50B | $ 17.78B | $ 12.97B |
| Total Debt | $ 174.30M | $ 1.41B | $ 1.20B | $ 11.00M | $ 14.06M |
| Net Debt | $ 174.30M | $ 1.00B | $ 763.97M | $ -459.78M | $ -648.15M |
| Total Liabilities | $ 2.79B | $ 3.56B | $ 3.89B | $ 4.11B | $ 3.09B |
| Stockholders' Equity | $ 6.57B | $ 8.74B | $ 9.62B | $ 13.67B | $ 9.88B |
| Cash Flow | |||||
| Free Cash Flow | $ 266.20M | $ 218.26M | $ 80.29M | $ 535.72M | $ 476.41M |
| Operating Cash Flow | $ 455.20M | $ 374.94M | $ 194.45M | $ 656.52M | $ 575.33M |
| Investing Cash Flow | $ -160.20M | $ 20.21M | $ -1.21B | $ -784.44M | $ -60.25M |
| Financing Cash Flow | $ -218.80M | $ -425.65M | $ 973.58M | $ -55.43M | $ -523.04M |